PA
CDMO

Perceptive Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Perceptive Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,476
Closed -$15K – 155
2017
Q2 		$15K Hold
3,476
– – ﹤0.01% 126
2017
Q1 		$16K Hold
3,476
– – ﹤0.01% 146
2016
Q4 		$8K Hold
3,476
– – ﹤0.01% 166
2016
Q3 		$10K Sell
3,476
-28,571
-89% -$76.7K ﹤0.01% 183
2016
Q2 		$81K Buy
32,047
+28,571
+822% +$79.6K 0.01% 149
2016
Q1 		$10K Buy
+3,476
New +$18.6K ﹤0.01% 166

Other funds holding CDMO

TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return

Perceptive Advisors's CDMO Position: Q3 2017 in Review

Perceptive Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2017, closing a stake of 3,476 shares — an estimated $15K sold.

Perceptive Advisors first reported a position in CDMO in Q1 2016 and held it in 6 quarters. The position peaked at $81K in Q2 2016. 53 funds tracked by Wall St. Rank hold CDMO as of Q3 2017.

  • Perceptive Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Perceptive Advisors sold 3,476 Avid Bioservices, Inc. Common Stock shares in Q3 2017, an estimated $15K.
  • Perceptive Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2016 and held it in 6 quarters.
  • Perceptive Advisors's Avid Bioservices, Inc. Common Stock position peaked at $81K in Q2 2016.
  • 53 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2017.

Based on Perceptive Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.